Clinical Trial of Pulmonary Cryptococcosis in China

Inclusion Criteria

• •Patients possess clinical or imaging manifestations of pulmonary infections,with any of the results(by one of following conditions) by microbiological examination or histopathologic examination
• •1. Cryptococcal capsular polysaccharide antigen of blood or pleural effusion is positive
• •2. Cryptococcus（fungus culture) is discovered by lower respiratory tract specimens
• •3. Cryptococcus（pleural effusions culture) is discovered by pleural effusions collected under sterile condition
• •4. Cryptococcus（pus culture) is discovered by pus smear out of pulmonary infections in disseminated infection patients
• •5. Cryptococcus（blood culture) is discovered by microscopy of specimens of blood smear
• •6. Cryptococcus is discovered by culturing of the pathological tissue specimens in aseptic condition
• •7. Cryptococcal capsular budding yeast with inflammatory reaction is discovered by histopathological examination,cell pathology examination or microscopic examination in aseptic condition